Moore Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-200,000
| Closed | -$8.56M | – | 149 |
|
|
2019
Q4 | $8.56M | Sell |
200,000
-41,653
| -17% | -$1.78M | 0.28% | 89 |
|
|
2019
Q3 | $8.7M | Sell |
241,653
-21,673
| -8% | -$780K | 0.35% | 79 |
|
|
2019
Q2 | $7.04M | Sell |
263,326
-44,124
| -14% | -$1.18M | 0.17% | 107 |
|
|
2019
Q1 | $8.26M | Buy |
+307,450
| New | +$8.26M | 0.25% | 97 |
|
|
2016
Q1 | – | Sell |
-100,000
| Closed | -$3.57M | – | 217 |
|
|
2015
Q4 | $3.57M | Buy |
+100,000
| New | +$3.57M | 0.11% | 144 |
|
|
2015
Q2 | – | Sell |
-80,000
| Closed | -$2.61M | – | 350 |
|
|
2015
Q1 | $2.61M | Buy |
+80,000
| New | +$2.61M | 0.06% | 191 |
|